The former commissioner was intimately involved in the FDA’s decision to approve hydroxychloroquine for emergency use during the pandemic
A congressional committee investigating the Trump administration's response to the coronavirus pandemic is calling former Food and Drug Administration Commissioner Stephen Hahn to appear for questioning.
According to its note to Hahn, the committee appears to be interested in asking the former FDA commissioner about his time dealing with the regulatory approvals of controversial drug products, the development of the Covid-19 vaccine and the White House’s interference in the FDA’s regulatory process. Hahn did not respond to a request for comment for this story.
In another instance, the FDA “rushed to issue an EUA for convalescent plasma,” according to the committee letter, penned by Chair Jim Clyburn . That emergency use authorization was issued despite objections from the National Institutes of Health.